Tag Archives: U.S. Senators

U.S. senators unveil bill to curb foreign espionage, influence on campuses

(Reuters) – A bipartisan group of U.S. senators introduced legislation on Thursday aimed at protecting research and innovation on U.S. campuses and preventing suspected theft of intellectual property by China and other countries.

There is a growing push in Washington to clamp down on spying and intellectual property theft that some Chinese nationals are suspected of engaging in at U.S. universities and colleges.

The “Safeguarding American Innovation Act” proposes to strengthen the U.S. State Department’s authority to deny visas to foreign nationals seeking access to certain sensitive technologies related to U.S. national security and economic security interests.

It also proposes penalizing individuals with fines and imprisonment for failing to disclose foreign support on federal grant applications, as well as lowering the threshold for U.S. schools and universities to report foreign gifts.

“This bill will help us stop foreign governments from stealing our research and innovation while also increasing transparency to ensure that taxpayers know when colleges and universities accept significant foreign funding,” Senator Rob Portman, a Republican and lead sponsor, said in a statement.

The bill, co-sponsored by at least nine Republicans and six Democrats, also aims to give the Department of Education authority to punish U.S. schools that fail to properly report gifts received from foreign entities.

In one of the highest-profile cases to emerge from a crackdown on Chinese influence within universities, a Harvard University professor pleaded not guilty on Tuesday to charges that he lied to authorities about his ties to a China-run recruitment program and funding he received from the Chinese government for research.

Reuters, citing sources, reported last month that the United States is planning to cancel the visas of thousands of Chinese graduate students believed by the Trump administration to have links with China’s military.

(Reporting by Ismail Shakil in Bengaluru; additional reporting by Patricia Zengerle in Washington; Editing by Mark Heinrich and Paul Simao)

Tempers rise in U.S. Senate as vote nears on $2 trillion coronavirus bill

By David Morgan and Richard Cowan

WASHINGTON (Reuters) – U.S. senators were set to vote on Wednesday on a $2 trillion bipartisan package of legislation to alleviate the devastating economic impact of the coronavirus pandemic, although critics from the right and left threatened to hold up the bill.

Top aides to Republican President Donald Trump and senior Senate Republicans and Democrats said they agreed on the unprecedented stimulus bill in the early hours of Wednesday after five days of talks.

The massive bill includes a $500 billion fund to help hard-hit industries and a comparable amount for direct payments of up to $3,000 apiece to millions of U.S. families.

Several Republican senators said the bill needed to be changed to ensure that laid-off workers would not be paid more than they earned on the job.

“This bill pays you more not to work than if you were working,” Republican Senator Lindsey Graham, a Trump ally, told a news conference.

In response, Senator Bernie Sanders, who is running for the Democratic presidential nomination, said he was prepared to block the bill if Republicans do not drop their objections.

That came after leaders of both parties predicted a Wednesday vote.

“Today the Senate will act to help the people of this country weather this storm,” Republican Senate Majority Leader Mitch McConnell said after the chamber convened at noon (1600 GMT).

Senate Democratic leader Chuck Schumer said his party was willing to pass the bill as quickly as possible.

“Help is on the way. Big help. Quick help,” he said on the Senate floor.

Trump is ready to sign the measure into law, the White House said, but it was unclear how quickly Congress could get the package to his desk. McConnell did not say what time the Senate would hold its vote, and the Democratic-controlled House of Representatives is not expected to act before Thursday.

The package will also include $350 billion for small-business loans, $250 billion for expanded unemployment aid and at least $100 billion for hospitals and related health systems.

It would be the largest rescue package ever approved by Congress and the third such effort to be passed this month. The money at stake amounts to nearly half of the $4.7 trillion the U.S. government spends annually.

‘DROP IN THE BUCKET’

New York Governor Andrew Cuomo said the $3.8 billion allocated to his state would not cover the tax revenue it stands to lose from reduced economic activity. His state accounts for roughly half of all U.S. coronavirus cases.

“That is a drop in the bucket,” he said at a news conference.

The package aims to flood the U.S. economy with cash in a bid to stem the impact of a pandemic that has killed 812 people in the United States and infected more than 59,200.

The governors of at least 18 states, including New York, have issued stay-at-home directives affecting about half the U.S. population. The sweeping orders are aimed at slowing the pathogen’s spread, but have upended daily life as schools and businesses shutter indefinitely.

On Wall Street, the benchmark S&P 500 <.SPX> rallied for a second straight day, closing up 1.15%. [nL1N2BI1YH]

Republican Senator Rand Paul, the only senator to vote against an earlier round of emergency virus funding, may be unable to vote after testing positive for COVID-19, the respiratory disease caused by the coronavirus.

It also must pass the House. Speaker Nancy Pelosi, who proposed a more far-reaching rescue package, did not say whether she would support the Senate version.

“We’ll see the bill and see how the Senate votes. So there’s no decision about timing until we see the bill,” she told reporters.

Any changes made by the House would also require Senate approval, which could lead to further delays.

The No. 2 House Democrat, Steny Hoyer, told lawmakers that they would be notified 24 hours before any action.

House members left Washington 10 days ago, but the lower chamber could quickly pass the bill without requiring their return, through a “voice vote” that would require only a few lawmakers to be present.

The top House Republican, Kevin McCarthy, said he would prefer that approach and called for its passage on Friday.

 

(Reporting by David Morgan and Richard Cowan; Additional reporting by Doina Chiacu, Lisa Lambert, Susan Cornwell and Andy Sullivan in Washington and Maria Caspani in New York; Writing by Patricia Zengerle and Andy Sullivann; Editing by Jonathan Oatis and Peter Cooney)

U.S. senators call for banning, prosecuting ‘slumlords’ of military housing

By M.B. Pell

NEW YORK (Reuters) – U.S. senators on Tuesday demanded the Defense Department crack down on private landlords who provide substandard housing at military bases with criminal prosecutions or contract cancellations, citing Reuters reports of slum-like living conditions and falsified accounting.

The top civilian and military leaders of the Army, Navy and Air Force appeared before the Senate Armed Services Committee, in the latest hearing addressing substandard military housing.

On Tuesday, senators were presented with a new report from the Government Accountability Office, a Congressional watchdog conducting a review of the housing program that was launched following the Reuters reports. Among the GAO’s core findings: Housing reports sent to Congress are often misleading, painting a falsely positive picture of housing conditions. The program also suffers from inaccurate landlord maintenance reports and lax military oversight, the GAO reported.

To read the GAO report, click: https://bit.ly/35UzZbC

Some senators asked whether the military’s two-decade-old program of having private landlords provide housing on U.S. military bases has failed.

“Are any of them not acting like slumlords at this point? Are any of them doing a good job?” asked Senator Martha McSally, an Arizona Republican and former U.S. Air Force combat pilot. “This pisses me off.”

For more than a year, Reuters has exposed lead, asbestos, mold and vermin contaminating homes where private landlords house thousands of military families on behalf of the Pentagon. More recently, the news agency disclosed how one major landlord doctored maintenance records at some of its bases to help it collect bonus incentive fees.

To read the coverage, click: https://reut.rs/2r1Bkim

Top Defense Department officials have long touted high occupancy rates and satisfaction scores on military family surveys as evidence the effort is generally successful, despite occasional hiccups. But Elizabeth A. Field, the GAO’s director of defense capabilities and management, told senators: “There’s clearly a problem here.”

Army Secretary Ryan McCarthy defended the privatization effort, saying it allowed the military to tap private borrowing that would otherwise be unavailable.

“That doesn’t mean it’s worked out great,” added Acting Navy Secretary Thomas B. Modly. Some privatized housing is “fantastic,” he said, but other housing is not.

The secretaries cited reform steps already taken, including far-reaching inspections of military housing and a planned tenant bill of rights to empower military families.

Senators pressed the secretaries to do more to hold accountable military leaders and landlords.

Oklahoma Republican Jim Inhofe, chair of the Senate Armed Services Committee, asked Air Force Secretary Barbara M. Barrett why she couldn’t “pull the plug” on Balfour Beatty Communities, one of the military’s largest landlords.

This year, Reuters quoted five former Balfour Beatty employees who said they filed false maintenance records at Air Force bases to help the company collect millions in bonus payments. Balfour Beatty, a unit of British infrastructure giant Balfour Beatty PLC <BALF.L>, has said that it is committed to improving its maintenance, and that it has tapped outside counsel and auditors to investigate.

Air Force Secretary Barrett said the Air Force has lost confidence in the company, but stopped short of committing to removing it from the program.

A company spokesman said Balfour Beatty plans this month to finish a “performance improvement plan” requested by the Air Force.

Democratic senators Richard Blumenthal, from Connecticut, and Mazie Hirono, from Hawaii, urged the military to refer instances of fraud for criminal prosecution.

“We probably need to make an example out of a couple of them,” said Senator Thom Tillis, a North Carolina Republican.

(Reporting by M.B. Pell in New York. Additional reporting by Joshua Schneyer. Editing by Ronnie Greene)

U.S. senators tell drug company executives pricing is ‘morally repugnant’

By Yasmeen Abutaleb and Michael Erman

WASHINGTON/NEW YORK (Reuters) – U.S. senators called drug pricing practices “morally repugnant” and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at a Senate hearing on the rising costs of prescription medicines.

Senators took aim in particular at Abbvie Inc Chief Executive Richard Gonzalez and his company’s rheumatoid arthritis drug Humira – the world’s top-selling prescription medicine.

Executives from AstraZeneca PLC, Sanofi SA, Pfizer Inc, Merck Co, Johnson & Johnson and Bristol-Myers Squibb Co also answered questions from members of the U.S. Senate Finance Committee.

The executives pointed to their companies’ records of developing lifesaving medications, saying profits generated in the lucrative U.S. market help them fund expensive research and development of future treatments.

“American research-based companies are leading the next wave of biomedical innovation to help patients whose diseases cannot be adequately treated with today’s medicines. We should work to ensure policies that support and reward these investments,” said Bristol-Myers CEO Giovanni Caforio.

The executives also voiced support for plans to reform the industry-wide system of rebates that pharmacy benefit managers (PBMs) and health insurers receive from drugmakers in exchange for preferential coverage of their medicines.

In his opening statement, Senator Ron Wyden, the Finance Committee’s top Democrat, tore into each company one-by-one for “profiteering and two-faced scheming.”

“Drugmakers behave as if patients and taxpayers are unlocked ATMs full of cash to be extracted, and their shareholders are the customers they value above all else,” Wyden said.

Senators from both parties targeted AbbVie’s Gonzalez, with Wyden noting that the CEO’s bonus was partially tied to Humira sales, which reached nearly $20 billion globally last year. Republican Senator John Cornyn criticized the company’s web of more than 130 patents that protects Humira’s exclusivity.

The drug has a list price of more than $60,000 a year, nearly double what it was in 2014, according to Rx Savings Solutions, which helps health plans and employers seek lower cost prescription medicines.

“I support drug companies recovering a profit based on their research and development and development of innovative drugs. But at some point, that patent has to end, that exclusivity has to end, to be able to get it at a much cheaper cost,” said Cornyn, the No. 2 Senate Republican from Texas.

Cornyn suggested that the powerful Senate Judiciary Committee should examine the U.S. patent system under which drug companies protect the exclusivity of their medicines.

Congress has already held several hearings on rising prescription drug prices in both the Democrat-controlled House of Representatives and the Republican-led Senate, but Tuesday’s hearing is the first time drug company executives, most of them CEOs, will face lawmakers in more than two years.

U.S. President Donald Trump has said drugmakers are “getting away with murder,” and his administration has made bringing down prescription medicine costs for U.S. consumers a top priority.

The U.S. Department of Health and Human Services (HHS) last year rolled out a plan to lower drug prices and has introduced several modest proposals to curb medicine costs, but Democrats have said the Trump administration is not doing enough.

HHS has proposed a rule to eliminate rebates for drugs paid for by Medicare and Medicaid, the government health insurance programs.

Several drugmakers temporarily froze price increases last year after criticism from Trump, but they raised prices on more than 250 prescription drugs at the start of this year, albeit at lower levels than in years past.

(Reporting by Yasmeen Abutaleb; editing by Jonathan Oatis and Bill Berkrot)

U.S. senators want probe of drug trafficking tied to Venezuela government

Venezuela's Vice President Tareck El Aissami talks to the media during a news conference in Caracas, Venezuela November 17, 2017.

By Patricia Zengerle

WASHINGTON (Reuters) – Two U.S. senators called on the U.S. Department of Justice on Wednesday to investigate allegations of drug trafficking by senior officials in the government of Venezuelan President Nicolas Maduro, as the country struggles with economic crisis.

In a letter to U.S. Attorney General Jeff Sessions seen by Reuters, Republican Senator Marco Rubio and Democrat Robert Menendez said they were concerned about possible connections between Maduro’s government and drug trafficking organizations and wanted an investigation “in order to better understand the nexus between criminal actors and members of Maduro’s inner circle.”

Despite being a major oil producing country, Venezuela is undergoing a severe economic and social crisis, with millions suffering food and medicine shortages, hyperinflation and growing insecurity.

Rubio is chairman of the Senate Foreign Relations Committee’s western hemisphere subcommittee, and Menendez is its ranking Democrat. Both lawmakers are vocal critics of the Venezuelan government.

In their letter, they raised concerns that the situation in Venezuela could destabilize the region.

The Venezuelan Information Ministry did not immediately respond to a request for comment. In the past, Maduro has dismissed accusations about drug trafficking links as a smear campaign by Washington, adding that the United States is to blame for the drug trade because it is such a large market for illegal narcotics.

On Aug. 1, 2016, a U.S. District Court announced the indictment of Nestor Reverol, who is now Venezuela’s interior minister, on charges of participating in an international cocaine trafficking conspiracy. In February 2017, the U.S. Treasury Department imposed sanctions against Venezuelan Vice President Tareck el-Aissami for drug trafficking and other related crimes.

And in December 2017, two nephews of Maduro’s wife, Franqui Francisco Flores de Freitas and Efrain Antonio Campo Flores, were convicted in U.S. federal court for drug smuggling.

The European Union announced new sanctions on several senior Venezuelan officials, including Reverol, on Monday, saying this was an expression of the bloc’s concern with the political crisis under Maduro.

Rubio and Menendez also asked Sessions to support efforts by the Organization of American States to address human rights concerns in Venezuela.

A Justice Department spokeswoman did not immediately respond to a request for comment on the letter, which was sent on Wednesday.

(Reporting by Patricia Zengerle; additional reporting by Brian Ellsworth in Caracas; editing by Susan Thomas)

U.S. senators urge Trump to take tough line on Russia over Ukraine

U.S. Senator Richard Durbin (D-IL) (C) talks with reporters after the weekly Democratic caucus policy luncheon at the U.S. Capitol in Washington, U.S.

By Patricia Zengerle

WASHINGTON (Reuters) – A bipartisan group of 27 U.S. senators sent a letter to President-elect Donald Trump on Thursday urging him to take a tough line against Russia over what they termed its “military land grab” in Ukraine.

The letter, whose 12 Republican and 15 Democratic signatories included some leading foreign policy voices from Trump’s Republican party, was an early sign that lawmakers will publicly assert themselves on international matters where they disagree with his White House.

The New York property developer becomes president on Jan. 20.

Trump signaled during his campaign that he might take a softer line in dealings with Moscow, repeatedly praising Russian President Vladimir Putin’s leadership. Putin said recently Trump confirmed to him that he was willing to mend ties.

“In light of Russia’s continued aggression and repeated refusal to respect Ukraine’s territorial integrity and sovereign right to choose its own destiny, we also renew our call for the United States to increase political, economic and military support for Ukraine,” said the letter, led by Senators Richard Durbin, a Democrat, and Rob Portman, a Republican, who are co-chairmen of the Senate Ukraine caucus.

In the letter, seen by Reuters before its public release, the senators also said they believe Russia’s annexation of Crimea should not be accepted and the United States should not lift sanctions imposed on Russia for its behavior in eastern Ukraine.

President Barack Obama and Putin have had a challenging relationship, with stark differences over Russia’s actions in Ukraine and Syria. Tensions have risen more with Obama’s Democratic Party in particular over cyber attacks attributed to Russia during the U.S. presidential election.

Among Republican senators who signed the letter were John McCain, chairman of the Senate Armed Services Committee, and Lindsey Graham, head of the appropriations subcommittee that oversees the State Department.

A majority of Republicans and Democrats on the Senate Foreign Relations Committee, including ranking Democrat Ben Cardin, signed the letter. Jack Reed, the top Democrat on Senate Armed Services, also did so.

(Reporting by Patricia Zengerle; Editing by Leslie Adler and Alistair Bell)